Pertuzumab trastuzumab and docetaxel is a combination treatment.
Docetaxel carboplatin trastuzumab and pertuzumab side effects.
In clinical studies the most commonly reported side effects with tchp are shown here.
This randomized phase iii trial studies docetaxel carboplatin trastuzumab and pertuzumab with estrogen deprivation to see how they work compared to docetaxel carboplatin trastuzumab and pertuzumab without estrogen deprivation in treating patients with hormone receptor positive human epidermal growth factor receptor 2 her2 positive breast cancer that is operable or has spread from.
Frequently occurring side effects diarrhoea constipation fatigue nausea and vomiting myelosuppression stomatitis and mucositis peripheral neuropathy arthralgia and myalgia other side effects alopecia fluid retention deranged liver function phlebitis skin toxicity nail changes.
When these medicines are given together drug related side effects reported in clinical studies give the best estimate of what to expect.
It is used to treat breast cancer that has spread to other areas or come back in the same area.
It is best to read this information with our general information about chemotherapy and targeted therapies.
Common side effects of perjeta include.